About this trial
The main aim of this randomized controlled clinical trial is to evaluate the efficacy of a bioactive glass desensitizer in reducing tooth sensitivity associated with in-office vital tooth bleaching. In addition, this study aims to compare the effectiveness of the bioactive glass desensitizer with that of a fluoride gel and a gel without desensitizing agent with regard to incidence, intensity, and duration of tooth sensitivity and, finally, to investigate how these agents affect tooth-shade following in-office bleaching. The hypothesis of the study is: There will be no difference in the effect of a bio-active glass desensitizer on tooth sensitivity associated with vital in-office tooth bleaching compared to a fluoride gel and the bio-active glass desensitizer has no effect on the bleaching efficacy.
Eligibility criteria
Qualifiers
At least eight maxillary anterior teeth present.
Age between 18 and 30 years Smokers
The selected teeth has a mean shade of C2 or darker (Vitapan Classical, Vita-Zahnfabrik, Sa¨ckingen, Germany)
Good general and oral health (no visible plaque or gingivitis)
Disqualifiers
Active caries and/or periodontal diseases (gingivitis and recession) or wasting diseases
Smokers
Pregnant/lactating women
Patients who have bleached their teeth previously
Trial design
Treatments tested in this trial
- Predicta® Bioactive Desensitizer (PBD, PARKELL, EDGEWOOD, NY, USA)
- Gel with 1.23% sodium fluoride (EAZIGEL, VERICOM CO., LTD. SOUTH KOREA)
- Placebo gel without any active ingredients.